<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The frequency and influence of dementia risk factors in prodromal Alzheimer&apos;s disease</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MSc</roleName><forename type="first">Isabelle</forename><surname>Bos</surname></persName>
							<email>isabelle.bos@maastrichtuniversity.nl</email>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychiatry and Neuropsychology</orgName>
								<orgName type="department" key="dep2">School for Mental Health and Neuroscience</orgName>
								<orgName type="institution" key="instit1">Maastricht University</orgName>
								<orgName type="institution" key="instit2">Alzheimer Center Limburg</orgName>
								<address>
									<settlement>Maastricht</settlement>
									<country key="NL">Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Stephanie</forename><forename type="middle">J</forename><surname>Vos</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychiatry and Neuropsychology</orgName>
								<orgName type="department" key="dep2">School for Mental Health and Neuroscience</orgName>
								<orgName type="institution" key="instit1">Maastricht University</orgName>
								<orgName type="institution" key="instit2">Alzheimer Center Limburg</orgName>
								<address>
									<settlement>Maastricht</settlement>
									<country key="NL">Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Lutz</forename><surname>Frölich</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">On behalf of German Dementia Competence Network</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Geriatric Psychiatry</orgName>
								<orgName type="department" key="dep2">Zentralinstitut für Seelische Gesundheit</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<settlement>Mannheim</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">&quot;G Papanicolau&quot; General Hospital</orgName>
								<address>
									<settlement>Thessaloniki</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Johannes</forename><surname>Kornhuber</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">On behalf of German Dementia Competence Network</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">Friedrich-Alexander University of Erlangen-Nürnberg</orgName>
								<address>
									<settlement>Erlangen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Jens</forename><surname>Wiltfang</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">On behalf of German Dementia Competence Network</orgName>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution" key="instit1">University Medical Center (UMC)</orgName>
								<orgName type="institution" key="instit2">Georg-August-University</orgName>
								<address>
									<settlement>Göttingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Wolfgang</forename><surname>Maier</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">On behalf of German Dementia Competence Network</orgName>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="department" key="dep2">German Center for Neurodegenerative Diseases (DZNE)</orgName>
								<orgName type="institution">University of Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Oliver</forename><surname>Peters</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">On behalf of German Dementia Competence Network</orgName>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">Charité Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Eckhart</forename><surname>Rüther</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">On behalf of German Dementia Competence Network</orgName>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">University of Göttingen</orgName>
								<address>
									<settlement>Göttingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Sebastiaan</forename><surname>Engelborghs</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Neurology and Memory Clinic</orgName>
								<orgName type="institution">Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken</orgName>
								<address>
									<settlement>Antwerp</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="laboratory">Reference Center for Biological Markers of Dementia (BIODEM)</orgName>
								<orgName type="institution">University of Antwerp</orgName>
								<address>
									<settlement>Antwerp</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Ellis</forename><surname>Niemantsverdriet</surname></persName>
							<affiliation key="aff10">
								<orgName type="laboratory">Reference Center for Biological Markers of Dementia (BIODEM)</orgName>
								<orgName type="institution">University of Antwerp</orgName>
								<address>
									<settlement>Antwerp</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Ellen</forename><forename type="middle">Elisa</forename><surname>De Roeck</surname></persName>
							<affiliation key="aff10">
								<orgName type="laboratory">Reference Center for Biological Markers of Dementia (BIODEM)</orgName>
								<orgName type="institution">University of Antwerp</orgName>
								<address>
									<settlement>Antwerp</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="department">Department of Clinical and Lifespan Psychology</orgName>
								<orgName type="institution">Vrije Universiteit Brussel</orgName>
								<address>
									<settlement>Brussels</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Magda</forename><surname>Tsolaki</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Memory and Dementia Center</orgName>
								<orgName type="institution">Aristotle University of Thessaloniki</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yvonne</forename><surname>Freund-Levi</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Department of Neurobiology, Caring Sciences and Society (NVS)</orgName>
								<orgName type="department" key="dep2">Division of Clinical Geriatrics</orgName>
								<orgName type="department" key="dep3">Department of Geriatric Medicine</orgName>
								<orgName type="institution" key="instit1">Karolinska Institutet</orgName>
								<orgName type="institution" key="instit2">Karolinska University Hospital Huddinge</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Peter</forename><surname>Johannsen</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Danish Dementia Research Centre</orgName>
								<orgName type="institution">Copenhagen University Hospital</orgName>
								<address>
									<settlement>Rigshospitalet, Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Rik</forename><surname>Vandenberghe</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">University Hospital Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="department">Department of Neurosciences</orgName>
								<orgName type="laboratory">Laboratory for Cognitive Neurology</orgName>
								<orgName type="institution">KU Leuven</orgName>
								<address>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Alberto</forename><surname>Lleó</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Hospital de la Santa Creu i Sant Pau</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Daniel</forename><surname>Alcolea</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Hospital de la Santa Creu i Sant Pau</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Giovanni</forename><forename type="middle">B</forename><surname>Frisoni</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University Hospitals and University of Geneva</orgName>
								<address>
									<settlement>Geneva</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="institution">IRCCS San Giovanni di Dio Fatebenefratelli</orgName>
								<address>
									<settlement>Brescia</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Samantha</forename><surname>Galluzzi</surname></persName>
							<affiliation key="aff20">
								<orgName type="institution">IRCCS San Giovanni di Dio Fatebenefratelli</orgName>
								<address>
									<settlement>Brescia</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Flavio</forename><surname>Nobili</surname></persName>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Clinical Neurology</orgName>
								<orgName type="department" key="dep2">Department of Neurosciences (DINOGMI)</orgName>
								<orgName type="institution">University of Genoa</orgName>
							</affiliation>
							<affiliation key="aff22">
								<orgName type="institution">IRCCS AOU San Martino-IST</orgName>
								<address>
									<settlement>Genoa</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Silvia</forename><surname>Morbelli</surname></persName>
							<affiliation key="aff23">
								<orgName type="department">Department of Health Science (DISSAL)</orgName>
								<orgName type="institution" key="instit1">Nuclear Medicine</orgName>
								<orgName type="institution" key="instit2">University of Genoa IRCCS AOU San Martino-IST</orgName>
								<address>
									<settlement>Genoa</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Alexander</forename><surname>Drzezga</surname></persName>
							<affiliation key="aff24">
								<orgName type="department">Department of Nuclear Medicine</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Mira</forename><surname>Didic</surname></persName>
							<affiliation key="aff25">
								<orgName type="department">Service de Neurologie et Neuropsychologie</orgName>
								<orgName type="institution">AP-HM Hôpitaux de la Timone</orgName>
								<address>
									<settlement>Marseille</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff26">
								<orgName type="department">Institut de Neurosciences des Systèmes</orgName>
								<orgName type="institution" key="instit1">Aix-Marseille Université</orgName>
								<orgName type="institution" key="instit2">INSERM</orgName>
								<address>
									<settlement>Marseille</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Bart</forename><forename type="middle">N</forename><surname>Van Berckel</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Eric</forename><surname>Salmon</surname></persName>
							<affiliation key="aff27">
								<orgName type="department">Department of Radiology and Nuclear Medicine</orgName>
								<orgName type="institution">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff28">
								<orgName type="department">Department of Neurology and Memory Clinic</orgName>
								<orgName type="institution">CHU Liège</orgName>
								<address>
									<settlement>Liège</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
							<affiliation key="aff29">
								<orgName type="institution" key="instit1">GIGA-CRC in vivo Imaging</orgName>
								<orgName type="institution" key="instit2">University of Liège</orgName>
								<address>
									<settlement>Liège</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Christine</forename><surname>Bastin</surname></persName>
							<affiliation key="aff29">
								<orgName type="institution" key="instit1">GIGA-CRC in vivo Imaging</orgName>
								<orgName type="institution" key="instit2">University of Liège</orgName>
								<address>
									<settlement>Liège</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Solene</forename><surname>Dauby</surname></persName>
							<affiliation key="aff28">
								<orgName type="department">Department of Neurology and Memory Clinic</orgName>
								<orgName type="institution">CHU Liège</orgName>
								<address>
									<settlement>Liège</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Isabel</forename><surname>Santana</surname></persName>
							<affiliation key="aff30">
								<orgName type="department" key="dep1">Center for Neuroscience and Cell Biology</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="department" key="dep3">Department of Neurology</orgName>
								<orgName type="institution">Centro Hospitalar e Universitário de Coimbra</orgName>
								<address>
									<settlement>Coimbra</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Inês</forename><surname>Baldeiras</surname></persName>
							<affiliation key="aff30">
								<orgName type="department" key="dep1">Center for Neuroscience and Cell Biology</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="department" key="dep3">Department of Neurology</orgName>
								<orgName type="institution">Centro Hospitalar e Universitário de Coimbra</orgName>
								<address>
									<settlement>Coimbra</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Alexandre</forename><surname>De Mendonça</surname></persName>
							<affiliation key="aff31">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of Lisbon</orgName>
								<address>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Dina</forename><surname>Silva</surname></persName>
							<affiliation key="aff31">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of Lisbon</orgName>
								<address>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Anders</forename><surname>Wallin</surname></persName>
							<affiliation key="aff32">
								<orgName type="department" key="dep1">Department of Psychiatry and Neurochemistry</orgName>
								<orgName type="department" key="dep2">Institute of Neuroscience and Physiology</orgName>
								<orgName type="department" key="dep3">Sahlgrenska Academy</orgName>
								<orgName type="institution">University of Gothenburg</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Arto</forename><surname>Nordlund</surname></persName>
							<affiliation key="aff32">
								<orgName type="department" key="dep1">Department of Psychiatry and Neurochemistry</orgName>
								<orgName type="department" key="dep2">Institute of Neuroscience and Physiology</orgName>
								<orgName type="department" key="dep3">Sahlgrenska Academy</orgName>
								<orgName type="institution">University of Gothenburg</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Preciosa</forename><forename type="middle">M</forename><surname>Coloma</surname></persName>
							<affiliation key="aff33">
								<orgName type="department">Pharmaceuticals Division</orgName>
								<orgName type="institution">Real World Data Science (RWD-S) Neuroscience and Established Products, F. Hoffmann-La Roche Ltd</orgName>
								<address>
									<settlement>Basel</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Angelika</forename><surname>Wientzek</surname></persName>
							<affiliation key="aff34">
								<orgName type="laboratory">PDB RWD (Real World Data) Team</orgName>
								<orgName type="institution">Roche Products Limited</orgName>
								<address>
									<settlement>Welwyn Garden City</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
							<affiliation key="aff35">
								<orgName type="institution">Epidemiologische Beratung und Literatur-Recherche &quot;conepi&quot;</orgName>
								<address>
									<settlement>Herrsching</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Myriam</forename><surname>Alexander</surname></persName>
							<affiliation key="aff34">
								<orgName type="laboratory">PDB RWD (Real World Data) Team</orgName>
								<orgName type="institution">Roche Products Limited</orgName>
								<address>
									<settlement>Welwyn Garden City</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Gerald</forename><forename type="middle">P</forename><surname>Novak</surname></persName>
							<affiliation key="aff36">
								<orgName type="institution">Janssen Pharmaceutical Research and Development</orgName>
								<address>
									<settlement>Titusville</settlement>
									<region>NJ</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Mark</forename><forename type="middle">Forrest</forename><surname>Gordon</surname></persName>
							<affiliation key="aff37">
								<orgName type="institution">Boehringer Ingelheim Pharmaceuticals, Inc</orgName>
								<address>
									<settlement>Ridgefield</settlement>
									<region>CT</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Neuroimaging</forename><surname>Initiative</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Åsa</forename><forename type="middle">K</forename><surname>Wallin</surname></persName>
							<affiliation key="aff38">
								<orgName type="department">Department of Clinical Sciences Malmö</orgName>
								<orgName type="institution" key="instit1">Lund University</orgName>
								<orgName type="institution" key="instit2">Clinical Memory Research Unit</orgName>
								<address>
									<settlement>Lund</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Harald</forename><surname>Hampel</surname></persName>
							<affiliation key="aff39">
								<orgName type="institution" key="instit1">Sorbonne Universités</orgName>
								<orgName type="institution" key="instit2">Université Pierre et Marie Curie</orgName>
								<address>
									<addrLine>Paris 06</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff40">
								<orgName type="department">Institut du Cerveau et de la Moelle épinière (ICM)</orgName>
								<orgName type="laboratory">Institut de la Mémoire et de la Maladie d&apos;Alzheimer (IM2A)</orgName>
								<orgName type="institution">AXA Research Fund &amp; UPMC Chair</orgName>
							</affiliation>
							<affiliation key="aff41">
								<orgName type="department">Département de Neurologie</orgName>
								<orgName type="institution">Hôpital de la Pitié-Salpétrière</orgName>
								<address>
									<addrLine>47 Boulevard de l&apos;Hôpital</addrLine>
									<postCode>75651</postCode>
									<settlement>Paris, CEDEX 13</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Hilkka</forename><surname>Soininen</surname></persName>
							<affiliation key="aff42">
								<orgName type="department">Institute of Clinical Medicine</orgName>
								<orgName type="institution">University of Eastern Finland and Neurocenter</orgName>
								<address>
									<settlement>Neurology, Neurology</settlement>
								</address>
							</affiliation>
							<affiliation key="aff43">
								<orgName type="institution">Kuopio University Hospital</orgName>
								<address>
									<settlement>Kuopio</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Sanna-Kaisa</forename><surname>Herukka</surname></persName>
							<affiliation key="aff42">
								<orgName type="department">Institute of Clinical Medicine</orgName>
								<orgName type="institution">University of Eastern Finland and Neurocenter</orgName>
								<address>
									<settlement>Neurology, Neurology</settlement>
								</address>
							</affiliation>
							<affiliation key="aff43">
								<orgName type="institution">Kuopio University Hospital</orgName>
								<address>
									<settlement>Kuopio</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Philip</forename><surname>Scheltens</surname></persName>
							<affiliation key="aff44">
								<orgName type="department">Alzheimer Center &amp; Department of Neurology</orgName>
								<orgName type="institution" key="instit1">Neuroscience Campus Amsterdam</orgName>
								<orgName type="institution" key="instit2">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Frans</forename><forename type="middle">R</forename><surname>Verhey</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychiatry and Neuropsychology</orgName>
								<orgName type="department" key="dep2">School for Mental Health and Neuroscience</orgName>
								<orgName type="institution" key="instit1">Maastricht University</orgName>
								<orgName type="institution" key="instit2">Alzheimer Center Limburg</orgName>
								<address>
									<settlement>Maastricht</settlement>
									<country key="NL">Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Pieter</forename><forename type="middle">Jelle</forename><surname>Visser</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychiatry and Neuropsychology</orgName>
								<orgName type="department" key="dep2">School for Mental Health and Neuroscience</orgName>
								<orgName type="institution" key="instit1">Maastricht University</orgName>
								<orgName type="institution" key="instit2">Alzheimer Center Limburg</orgName>
								<address>
									<settlement>Maastricht</settlement>
									<country key="NL">Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff44">
								<orgName type="department">Alzheimer Center &amp; Department of Neurology</orgName>
								<orgName type="institution" key="instit1">Neuroscience Campus Amsterdam</orgName>
								<orgName type="institution" key="instit2">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">the Alzheimer&apos;s Disease</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff45">
								<orgName type="department" key="dep1">Department of Psychiatry &amp; Neuropsychology</orgName>
								<orgName type="department" key="dep2">School for Mental Health and Neuroscience</orgName>
								<orgName type="department" key="dep3">Alzheimer Center Limburg</orgName>
								<orgName type="institution">Maastricht University Universiteitssingel 40</orgName>
								<address>
									<postBox>Box 34, P.O. Box 616</postBox>
									<postCode>6200 MD</postCode>
									<settlement>Maastricht</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The frequency and influence of dementia risk factors in prodromal Alzheimer&apos;s disease</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">D308982BCD9B0C5E68B0E477A55B6A07</idno>
					<idno type="DOI">10.1016/J.NEUROBIOLAGING.2017.03.034</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:45+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Alzheimer&apos;s disease</term>
					<term>risk factors</term>
					<term>IWG-2 criteria</term>
					<term>NIA-AA criteria</term>
					<term>biomarkers</term>
					<term>prognosis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>We investigated whether dementia risk factors were associated with prodromal Alzheimer's disease (AD) according to the International Working Group-2 and National Institute of Aging-Alzheimer's Association criteria, and with cognitive decline.</s><s>1394 subjects from with Mild Cognitive Impairment (MCI) from 14 different studies were classified according to these research criteria, based on cognitive performance and biomarkers.</s><s>We compared the frequency of ten risk factors between the subgroups and used Cox-regression to examine the effect of risk factors on cognitive decline.</s><s>Depression, obesity and hypercholesterolemia occurred more often in individuals with low-AD-likelihood, compared to those with a high-AD-likelihood.</s></p><p><s>Only alcohol use increased the risk of cognitive decline, regardless of AD pathology.</s></p><p><s>These results suggest that traditional risk factors for AD are not associated with prodromal AD or with progression to dementia, among subjects with MCI.</s><s>Future studies should validate these findings and determine whether risk factors might be of influence at an earlier stage (i.e.</s><s>preclinical) of AD.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Various risk factors have been associated with an increased risk for Alzheimer's disease (AD) <ref type="bibr" target="#b8">(Breteler, 2000;</ref><ref type="bibr" target="#b9">de Bruijn and Ikram, 2014)</ref>.</s><s>Recently, research criteria have been proposed to identify AD in subjects with mild cognitive impairment (MCI) by their biomarker status, referred to as prodromal AD by international working group-2 (IWG-2) <ref type="bibr" target="#b14">(Dubois, et al., 2014)</ref> and MCI due to AD by the National Institute of Aging-Alzheimer Association (NIA-AA) <ref type="bibr" target="#b0">(Albert, et al., 2011)</ref>.</s><s>It remains uncertain whether risk factors are associated with prodromal AD/ MCI due to AD, and whether they influence the rate of cognitive decline.</s><s>This information could improve early diagnosis and lead to new targets for secondary prevention strategies.</s></p><p><s>Among the best-validated risk factors for AD are atherosclerosis, depression, diabetes mellitus, hypercholesterolemia, hypertension, lacunar infarcts, stroke, obesity, smoking, and alcohol consumption <ref type="bibr" target="#b8">(Breteler, 2000;</ref><ref type="bibr" target="#b9">de Bruijn and Ikram, 2014;</ref><ref type="bibr" target="#b11">Deckers, et al., 2015)</ref>.</s><s>Diabetes mellitus, depression, hypertension, stroke and cardiovascular diseases have also been associated with an increased risk of progressing from cognitively normal to MCI <ref type="bibr" target="#b27">(Pankratz, et al., 2015;</ref><ref type="bibr" target="#b29">Roberts, et al., 2015)</ref>.</s><s>Moreover, an association with cognitive decline has been found in both cognitively normal and MCI subjects <ref type="bibr" target="#b18">(Jefferson, et al., 2015;</ref><ref type="bibr" target="#b20">Kaffashian, et al., 2013)</ref>.</s></p><p><s>Therefore, we hypothesize that risk factors will occur more frequently in individuals with prodromal AD/MCI due to AD.</s><s>We also expect that risk factors will increase the risk of progression to dementia.</s></p><p><s>We aim to investigate the frequency of several risk factors in individuals with prodromal AD/MCI due to AD, classified according to the IWG-2 and NIA-AA criteria, relative to subjects who do not meet these criteria.</s><s>Secondly, we aim to examine whether risk factors influence the rate of cognitive decline.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">Subjects</head><p><s>Subjects were recruited from five multicenter memory-clinic based studies: DESCRIPA <ref type="bibr" target="#b34">(Visser, et al., 2008)</ref>, German Dementia Competence Network (DCN) <ref type="bibr" target="#b22">(Kornhuber, et al., 2009)</ref>, EDAR (www.edarstudy.eu), the European Alzheimer's Disease Consortium (EADC)-PET study <ref type="bibr" target="#b25">(Morbelli, et al., 2012)</ref> and American Alzheimer's Disease Neuroimaging Initiative (ADNI-1) study <ref type="bibr" target="#b26">(Mueller, et al., 2005)</ref>; and nine centers of the EADC and/or European Medical Information Framework (EMIF)-AD: Amsterdam (van der <ref type="bibr" target="#b33">Flier, et al., 2014)</ref>, Antwerp <ref type="bibr">(Somers C., In press)</ref>, Barcelona <ref type="bibr" target="#b1">(Alcolea, et al., 2014)</ref>, Brescia <ref type="bibr" target="#b15">(Frisoni, et al., 2009)</ref>, Coimbra <ref type="bibr" target="#b5">(Baldeiras, et al., 2008</ref><ref type="bibr">), Gothenburg(Wallin, et al., 2016)</ref>, Kuopio <ref type="bibr" target="#b31">(Seppala, et al., 2011)</ref>, Liège <ref type="bibr" target="#b6">(Bastin, et al., 2010)</ref> and Lisbon <ref type="bibr" target="#b23">(Maroco, et al., 2011)</ref>.</s><s>For subjects who participated in more than one study, we used data from the study with the longest follow-up.</s></p><p><s>Inclusion criteria consisted of baseline diagnosis of MCI according to the criteria of Petersen <ref type="bibr" target="#b28">(Petersen, 2004)</ref>, and at least one of the following biomarkers available at baseline: amyloid-beta (Aβ) 1-42 and tau (total tau and/or phosphorylated tau) in CSF, hippocampal volume on magnetic resonance imaging (MRI) or cerebral glucose metabolism on [18F]FDG-PET of the brain.</s><s>Moreover, baseline data had to be available on at least one of the selected risk factors, as well as information on educational level and at least one clinical follow-up assessment.</s><s>Exclusion criteria were diagnosis of dementia at baseline.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Clinical assessment</head><p><s>The clinical assessment is described in detail by <ref type="bibr" target="#b35">Vos et al. (Vos, et al., 2015)</ref>.</s><s>In short, clinical assessment was performed at each site according to local routine protocol.</s></p><p><s>Cognitive impairment was defined as Z-score &lt; -1.5 SD on at least one neuropsychological test, which could be a memory or non-memory test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">Outcome at follow-up</head><p><s>Cognitive decline was defined as progression to dementia according to the Diagnostic and Statistical Manual of Mental Disorders <ref type="bibr" target="#b4">(APA, 1994)</ref>, or a decline on the Mini-Mental State Examination (MMSE) of at least 3 points at follow-up.</s><s>We used a combination of these two measures, as for a subgroup (n=17) no clinical diagnosis at follow-up was available.</s><s>For sub analyses, diagnosis of AD-type dementia at followup was made according to the National Institute of Neurological and Communicative Disorders and Stroke -Alzheimer's Disease and Related Disorders Association criteria (NINCDS-ADRDA) <ref type="bibr" target="#b24">(McKhann, et al., 1984)</ref>.</s></p><p><s>The medical ethics committee at each site approved the study.</s><s>All subjects provided informed consent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">Biomarker assessment</head><p><s>Biomarker assessment was performed according to the routine protocol at each site and center-specific cut-offs were used to define abnormality, as described elsewhere <ref type="bibr" target="#b35">(Vos, et al., 2015)</ref>.</s><s>Examination of medial temporal lobe atrophy on MRI and cerebral glucose metabolism on FDG-PET were performed through visual assessment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5">Subject classification</head><p><s>Subjects were classified as having prodromal AD according to the IWG-2 criteria using CSF Aβ1-42 and tau biomarkers (Table <ref type="table" target="#tab_0">1</ref>).</s><s>The NIA-AA criteria distinguish between six groups that indicate the likelihood that MCI is due to AD, based on combinations of amyloid and neuronal injury markers.</s><s>We used CSF Aβ1-42 as amyloid marker and CSF total tau, CSF phosphorylated tau, cerebral glucose metabolism on FDG-PET, hippocampal volume or medial temporal lobe atrophy on MRI as neuronal injury markers (Table <ref type="table" target="#tab_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6">Risk factors</head><p><s>We assessed the following risk factors at baseline: atherosclerotic disease, depression, diabetes, hypercholesterolemia, hypertension, lacunar infarct, obesity, stroke, current smoking, and current alcohol use.</s><s>Not all risk factors were available for each subject.</s></p><p><s>Supplemental Table <ref type="table" target="#tab_0">1</ref> provides an overview of the available risk factors for each center.</s><s>The risk factor definitions are described by center in Supplemental Table <ref type="table" target="#tab_1">2</ref>.</s></p><p><s>For all risk factors occurrence in medical history was used as a standard.</s><s>For some risk factors, we used additional definitions based on rating scales, physical measurements or medication use, based on availability (Supplemental Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.7">Statistical analyses</head><p><s>Baseline differences between the biomarker profile groups were analyzed using ANOVA for continuous variables and Chi-Square test for categorical variables.</s><s>The relation of risk factors with prodromal AD/MCI due to AD was tested with logistic regression (IWG-2 criteria) or multinomial regression (NIA-AA criteria).</s><s>Cox proportional hazards models were used to test the effect of each risk factor on the rate of cognitive decline in the total sample, and for the IWG-2 and NIA-AA biomarker subgroups.</s><s>All analyses were adjusted for age, sex, education and center.</s><s>Statistical analyses were performed using SPSS version 22.0 with the significance level set at p&lt;0.05.</s><s>We corrected for multiple comparisons, using the false discovery rate (FDR) adjustment <ref type="bibr" target="#b7">(Benjamini and Hochberg, 1995)</ref>, taking into account the testing of ten risk factors.</s><s>In tables, we reported uncorrected p-values and we indicated which associations were significant after correction for multiple comparisons in tables and the text.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">Subject characteristics</head><p><s>We included 1394 individuals (mean age = 69.7,</s><s>SD 8.3; 51% female).</s><s>Seven hundred and fifty-eight subjects had data available on both amyloid and neuronal injury markers, while 636 subjects only had data on a neuronal injury marker (medial temporal lobe atrophy n=528, FDG-PET n=108).</s><s>Five hundred and eighty individuals (42%) showed cognitive decline after an average follow-up time of 2.3 (SD 1.2) years.</s><s>Table <ref type="table" target="#tab_1">2</ref> shows the characteristics of the subjects classified according to the IWG-2 and the NIA-AA criteria.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">Analyses in subjects with both amyloid and neuronal injury markers</head><p><s>Based on the IWG-2 criteria, 302 subjects (40%) were classified as prodromal AD.</s></p><p><s>Individuals with prodromal AD were older (p&lt;0.001),</s><s>showed a lower score on the MMSE at follow-up (p&lt;0.001) and were more likely to progress to AD-type dementia at follow-up (p&lt;0.001) compared to subjects without prodromal AD.</s><s>According to the NIA-AA criteria, 142 individuals (10%) were classified in the low-AD-likelihood group, 356 (26%) in the high-AD-likelihood group, 54 (4%) in the Isolated Amyloid Pathology (IAP) group, and 206 (15%) in the Suspected Non-AD Pathophysiology (SNAP) group.</s><s>Subjects in the high-AD-likelihood group were older and most likely to progress to AD-type dementia, compared to all other groups (Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.1.">Frequency of risk factors</head><p><s>Table <ref type="table" target="#tab_2">3</ref> shows the frequency of AD risk factors for the NIA-AA groups with both amyloid and neuronal injury data.</s><s>Compared to the high-AD-likelihood group, subjects in the low-AD-likelihood group had a higher frequency of depression (46% vs. 17%, p=0.004,</s><s>FDR p=0.020), obesity (21% vs. 8%, p=0.004,</s><s>FDR p=0.020) and hypercholesterolemia (43% vs. 27%, p=0.009,</s><s>FDR p=0.030).</s><s>No differences were found between the groups for the other risk factors (Table <ref type="table" target="#tab_2">3</ref>).</s></p><p><s>Supplemental Table <ref type="table" target="#tab_2">3</ref> shows the frequency of risk factors for the groups according to the IWG-2 criteria.</s><s>In the group without prodromal AD we found higher frequencies of depression (34% vs. 16%, p=0.009,</s><s>FDR p=0.045) and obesity (17% vs. 8%, p=0.007,</s><s>FDR p=0.045) compared to the group with prodromal AD (Supplemental Table <ref type="table" target="#tab_2">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.2.">Effect of risk factors on cognitive decline</head><p><s>In the total group of subjects with both amyloid and neuronal injury markers, alcohol use was associated with a higher risk of cognitive decline (HR=1.5, p=0.003,</s><s>FDR p=0.030,</s><s>Table <ref type="table" target="#tab_3">4</ref>).</s><s>There were no significant interactions between risk factors and NIA-AA group classification, indicating that the effect of risk factors was similar for all groups.</s><s>Using the IWG-2 classification, the effects of depression, hypercholesterolemia, and smoking were different between the two groups, but these differences were no longer statistical significant after adjusting for multiple testing (Table <ref type="table" target="#tab_3">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">Analyses in subjects with only neuronal injury markers</head><p><s>Table <ref type="table" target="#tab_1">2</ref> shows the characteristics of the 258 (21%) subjects classified as uninformative/inconclusive and the 350 (25%) included in the intermediate-ADlikelihood group according to the NIA-AA criteria.</s><s>The subjects in the intermediate-AD-likelihood differed on all characteristics from the uninformative/inconclusive group.</s></p><p><s>The frequency of risk factors for the subjects who had only neuronal injury markers available is described in Supplemental Table <ref type="table" target="#tab_3">4</ref>.</s><s>In the intermediate-AD-likelihoodgroup lacunar infarcts occurred more frequently (40%), compared to the uninformative/inconclusive group (16%, p&lt;0.001).</s><s>There were no differences for the other risk factors (Supplemental Table <ref type="table" target="#tab_3">4</ref>).</s></p><p><s>In the subjects with only neuronal injury markers available, none of the risk factors increased the risk of cognitive decline.</s><s>Also, there was no difference between the two NIA-AA groups in the rate of cognitive decline (Supplemental Table <ref type="table">5</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">Post-hoc analysesprogression to AD-type dementia</head><p><s>When we repeated the analyses with only progression to AD-type dementia as an outcome in subjects with both amyloid and neuronal injury markers available (n=725), alcohol use was no longer associated with an increased risk of progression (HR=1.3,</s><s>95% CI: 0.9 -1.8, p=0.164).</s></p><p><s>Since the ADNI cohort excluded subjects with depressive symptoms (GDS&gt;6), we repeated the analyses concerning depression without ADNI subjects.</s><s>This did not influence the results.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p><s>We examined the frequency of vascular and lifestyle risk factors in prodromal AD/MCI due to AD, and the influence of these factors on cognitive decline, in subjects with MCI.</s><s>We found that the frequencies of depression, hypercholesterolemia and obesity were higher in the group without AD pathology compared to the group with AD pathology.</s><s>Only alcohol increased the risk of cognitive decline, regardless of AD-pathology.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1">Frequency of risk factors</head><p><s>Contrary to our hypothesis we found higher frequencies of depression, hypercholesterolemia and obesity, in the group without prodromal AD and in the low-AD-likelihood group.</s><s>This suggests that subjects without prodromal AD or low-ADlikelihood had cognitive impairment due to other causes than AD, such as depression or vascular disorders <ref type="bibr" target="#b10">(DeCarli, 2003;</ref><ref type="bibr" target="#b16">Gorelick, et al., 2011)</ref>.</s><s>It is also possible that low cholesterol or low body mass index are risk factors for prodromal AD in this elderly sample.</s><s>While obesity and hypercholesterolemia in middle age have been shown to be predictive for AD <ref type="bibr" target="#b11">(Deckers, et al., 2015;</ref><ref type="bibr" target="#b21">Kivipelto, et al., 2005)</ref>, other studies showed that this association is reversed at older age, such that low body mass index and low cholesterol increase the risk for AD <ref type="bibr" target="#b2">(Anstey, et al., 2008;</ref><ref type="bibr" target="#b19">Johnson, et al., 2006)</ref>.</s><s>When we compared the frequencies observed in the current study to the prevalence of risk factors reported in meta-analyses and population-based cohort studies (Supplemental Table <ref type="table">6</ref>), we found that the frequencies of obesity and hypercholesterolemia in the high-AD-likelihood group were decreased, while frequencies were similar in subjects with a low-AD-likelihood.</s><s>On the contrary, the frequency of depression in the high-AD-likelihood group was similar to that in the general population while it was higher in the low-AD-likelihood group compared to the population-based studies.</s><s>This would suggest that the difference in frequencies of obesity and hypercholesterolemia between the low and high-AD-likelihood in our study results from a decrease of obesity and hypercholesterolemia in the high-ADlikelihood, rather than from an increase in the low-AD-likelihood.</s><s>Conversely, the difference in frequency in depression between groups could result from an increase in frequency of depression in the low-AD-likelihood.</s><s>This indicates that depression can be a possible cause of MCI in the studied population <ref type="bibr" target="#b10">(DeCarli, 2003;</ref><ref type="bibr" target="#b12">Defrancesco, et al., 2009)</ref>.</s><s>Clearly there are methodological differences in the inclusion of subjects, definition and method of ascertainment of risk factors and age range between the current study and the population based studies.</s><s>Studies that directly compare frequency of risk factors in prodromal AD to cognitively normal subjects are needed to further clarify this.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2">Influence of risk factors on cognitive decline</head><p><s>Alcohol consumption was associated with an increased risk of cognitive decline, independent of AD-pathology.</s><s>Although this finding is in line with several previous studies <ref type="bibr" target="#b11">(Deckers, et al., 2015;</ref><ref type="bibr" target="#b17">Jauhar, et al., 2014)</ref> that identified alcohol as a risk factor for cognitive decline, other studies have reported a protective or no relation to alcohol consumption with incident AD <ref type="bibr" target="#b3">(Anstey, et al., 2009;</ref><ref type="bibr" target="#b30">Ruitenberg, et al., 2002)</ref>.</s></p><p><s>These conflicting results could be explained by differences in study population (MCI versus cognitively normal), definitions of alcohol consumption (dichotomous versus categories based on the amount of alcohol use) and the type of alcohol.</s><s>When conversion to AD-type dementia was used as outcome instead of conversion to dementia or a decline on the MMSE, we found that the effect of alcohol was no longer significant.</s><s>This suggests that alcohol consumption mainly has an effect on progression to non-AD types of dementia or cognitive decline in general.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3">IWG-2 vs. NIA-AA criteria</head><p><s>The results on frequency of risk factors were comparable for the IWG-2 and NIA-AA criteria.</s><s>Also, when comparing the effect of risk factors on cognitive decline we found similar outcomes when using the two sets of criteria.</s><s>This shows that although the IWG-2 criteria only classify neuronal injury based on tau in CSF and the NIA-AA criteria also include other neuronal injury markers, this did not influence the results.</s></p><p><s>Although the outcomes were similar for the two sets of criteria, the NIA-AA criteria provided more insight into which specific biomarker profile was associated with a higher frequency of a certain risk factor, which could be useful to give a more refined diagnosis and prognosis of early AD and age-related comorbidities.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.4">Strengths and limitations of the study</head><p><s>Strengths of the study are the large sample size, the broad spectrum of assessed risk factors and longitudinal data on clinical outcome.</s><s>There are also limitations to this study that should be mentioned.</s><s>Some of the biomarker subgroups were small and some risk factors were only available in a subgroup or had a low frequency, which limited statistical power.</s><s>The data used in this study was contributed by different centers and data was not collected using the same protocol.</s><s>This might have led to variability, although it does reflect current clinical practice.</s><s>Furthermore, the use of indirect measures (e.g.</s><s>medical history) of risk factors could have introduced heterogeneity in classification.</s><s>We were unable to study the potential interactions between risk factors, as not all centers contributed data on all risk factors.</s><s>We had only limited data available on medication use, which did not allow us to control for this.</s><s>Also, we could not correct for the duration and the severity of a risk factor, as we had no information on this.</s><s>Although the mean follow-up was 2.3 years, some individuals likely would have shown cognitive decline at a later stage.</s><s>Since these findings are based on clinical research populations, they may not be generalizable to other settings.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.5">Conclusion</head><p><s>In summary, we found that dementia risk factors were not associated with prodromal Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.</s><s>Brain : a journal of neurology 138(Pt 5), <ref type="bibr">1327</ref><ref type="bibr">-38. Wallin, A., Nordlund, A., Jonsson, M., Blennow, K., Zetterberg, H., Ohrfelt, A., Stalhammar, J., Eckerstrom, M., Carlsson, M., Olsson, E., Gothlin, M., Svensson, J., Rolstad, S., Eckerstrom, C., Bjerke, M. 2016</ref>.</s><s>Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.</s><s>J Cereb Blood Flow Metab 36(1), 95-113.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>AD/MCI due to AD in subjects with MCI, and only alcohol increased the risk of cognitive decline, regardless of underlying pathology.</s><s>Moreover, we found that a lower frequency of hypercholesterolemia or obesity may be indicative of early AD in an elderly population.</s><s>Although our findings should be validated in future studies, they could have implications for clinical practice, future scientific studies, as well as for selection of individuals for participation in clinical trials.</s><s>Different risk factor profiles in subjects with MCI could be related to distinct etiologies of cognitive dysfunction, and therefore may have different prognostic values.</s><s>Management of alcohol habits could possibly lessen or prevent further cognitive decline.</s><s>Future studies should focus on the role of risk factors in even earlier stages of AD (e.g.</s><s>preclinical AD), examine longitudinal biomarkers values, and consider the duration and severity of risk factors.</s><s>Also, co-occurrence of risk factors and possible synergistic effects on biomarkers should be a topic for future research as we were unable to study this in the current sample.</s><s>related to the randomized clinical trials came from Janssen-Cilag and Merz Pharmaceuticals.</s><s>The latter funds were exclusively used for personnel, pharmaceuticals, blistering and shipment of medication, monitoring and as capitation fees for recruiting centers.</s><s>The DESCRIPA study was funded by the European Commission within the 5th framework program (QLRT-2001-2455).</s><s>The EDAR study was funded by the European Commission within the 5th framework program (contract # 37670.</s><s>The Coimbra center was funded by Project PIC/IC/ 83206/2007 da Fundação para a Ciência e Tecnologia -Portugal.</s><s>Research of the VUmc Alzheimer center is part of the neurodegeneration research program of the Neuroscience Campus Amsterdam.</s><s>The VUmc Alzheimer Center is supported by Alzheimer Nederland and Stichting VUmc fonds.</s><s>The clinical database structure was developed with funding from Stichting Dioraphte.</s><s>The Alzheimer's Disease Neuroimaging Initiative (ADNI; National Institutes of Health Grant U01 AG024904 and DOD ADNI Department of Defense award number W81XWH-12-2-0012) was funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research &amp; Development, LLC.; Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC.; Medpace, Inc.; Merck &amp; Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company.</s><s>The Canadian Institutes of Health Research is providing funds to Rev December 5, 2013 support ADNI clinical sites in Canada.</s><s>Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).</s><s>The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego.</s><s>ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Aβ = amyloid-beta, AD = Alzheimer's disease, CSF = cerebrospinal fluid, FDG-PET = fluorodeoxyglucose-positron emission tomography, IAP = Isolated Amyloid Pathology, IWG = International Working Group, MRI = magnetic resonance imaging, NIA-AA = National Institute of Aging-Alzheimer's Association, p-tau = phosphorylated tau, SNAP = non-Alzheimer Pathophysiology, t-tau = total tau.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 : Classification of subjects according to IWG-2 and NIA-AA criteria</head><label>1</label><figDesc></figDesc><table><row><cell>Amyloid marker</cell><cell>Neuronal injury marker</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 : Demographics and clinical outcome according to IWG-2 and NIA-AA criteria</head><label>2</label><figDesc><div><p><s>Decline on MMSE at follow-up was defined as a difference of 3 points or more and was available in a subgroup of the samples: IWG-2 no prodromal AD n=237, prodromal AD n=223; NIA-AA low-AD-likelihood n=61, high-AD-likelihood n=259, IAP n=37, SNAP=103, uninformative/inconclusive n=184, intermediate-AD-likelihood n=233.</s><s>p&lt;0.05 compared to high-AD-likelihood after FDR correction, C p&lt;0.05 compared to IAP after FDR correction, D p&lt;0.05 compared to SNAP after FDR correction, # p&lt;0.05 compared to the uninformative/inconclusive after FDR correction.</s></p></div></figDesc><table><row><cell></cell><cell>IWG-2 criteria</cell><cell></cell><cell></cell><cell></cell><cell cols="3">NIA-AA criteria -Amyloid and neuronal injury markers</cell><cell></cell><cell cols="3">NIA-AA criteria-only neuronal injury markers</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Group A</cell><cell>Group B</cell><cell>Group C</cell><cell>Group D</cell><cell></cell><cell></cell></row><row><cell></cell><cell>No prodromal</cell><cell cols="2">Prodromal</cell><cell></cell><cell>Low-AD-</cell><cell>High-AD-</cell><cell>IAP</cell><cell>SNAP</cell><cell>Uninformative</cell><cell cols="2">Intermediate-AD-</cell></row><row><cell></cell><cell>AD</cell><cell>AD</cell><cell></cell><cell></cell><cell>likelihood</cell><cell>likelihood</cell><cell></cell><cell></cell><cell>/Inconclusive</cell><cell cols="2">likelihood</cell></row><row><cell></cell><cell>N=456</cell><cell>N=302</cell><cell></cell><cell></cell><cell>N=142</cell><cell>N=356</cell><cell>N=54</cell><cell>N=206</cell><cell>N=286</cell><cell>N=350</cell></row><row><cell>Age, years</cell><cell>67.3 (8.6)</cell><cell>71.3 (7.5)</cell><cell cols="2">¶</cell><cell>63.4 (8.9) B,D</cell><cell>71.3 (7.5) A,C,D</cell><cell>66.2 (7.5) B</cell><cell>69.2 (8.0) A,B</cell><cell>67.8 (8.4)</cell><cell>73.1 (7.2)</cell><cell>#</cell></row><row><cell>Female, n</cell><cell>207 (45%)</cell><cell cols="2">148 (49%)</cell><cell></cell><cell>64 (45%)</cell><cell>170 (48%)</cell><cell>25 (46%)</cell><cell>96 (46%)</cell><cell>183 (64%)</cell><cell cols="2">177 (50%) #</cell></row><row><cell>Education, years</cell><cell>10.4 (3.8)</cell><cell>11.7 (4.3)</cell><cell cols="2">¶</cell><cell>10.3 (3.2) B</cell><cell>11.6 (4.3) A,D</cell><cell>11.0 (4.0)</cell><cell>10.2 (3.9) B</cell><cell>9.9 (4.6)</cell><cell>10.7 (4.2)</cell><cell>#</cell></row><row><cell>Follow-up, years</cell><cell>2.3 (1.2)</cell><cell>2.3 (1.1)</cell><cell></cell><cell></cell><cell>2.1 (0.9)</cell><cell>2.3 (1.2)</cell><cell>2.3 (1.2)</cell><cell>2.4 (1.3)</cell><cell>2.6 (1.4)</cell><cell>2.3 (1.3) #</cell></row><row><cell>APOE-ε4 *</cell><cell>138 (35%)</cell><cell cols="2">184 (68%)</cell><cell>¶</cell><cell>37 (30%) B</cell><cell>205 (65%) A,D</cell><cell>22 (47%)</cell><cell>58 (32%) B</cell><cell>81 (36%)</cell><cell cols="2">141 (52%) #</cell></row><row><cell>MMSE at baseline</cell><cell>27.0 (2.3)</cell><cell>26.1 (2.5)</cell><cell cols="2">¶</cell><cell>27.5 (2.9) B,D</cell><cell>26.2 (2.5) A,C</cell><cell>27.3 (2.4) B</cell><cell>26.7 (2.3) A</cell><cell>27.5 (2.3)</cell><cell>26.6 (2.2)</cell><cell>#</cell></row><row><cell>Decline on MMSE</cell><cell>58 (25%)</cell><cell cols="2">114 (51%)</cell><cell>¶</cell><cell>8 (13%) B</cell><cell>127 (49%) A,C,D</cell><cell>6 (16%) B</cell><cell>31 (30%) B</cell><cell>329 (38%)</cell><cell cols="2">106 (45%) #</cell></row><row><cell>at follow-up  †</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Progression to AD-</cell><cell>86 (20%)</cell><cell cols="2">172 (59%)</cell><cell>¶</cell><cell>6 (5%) B,D</cell><cell>193 (56%) A,C,D</cell><cell>10 (20%) A,B</cell><cell>49 (24%) A,B</cell><cell>56 (19%)</cell><cell cols="2">167 (47%)</cell></row><row><cell>type dementia at</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>follow-up  ‡</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>† ‡ Progression to AD-type dementia at follow-up was available in a subgroup of the sample: IWG-2 no prodromal AD n=435, prodromal AD n=293, NIA-AA low-AD-likelihood n=134, high-AD-likelihood n=344, IAP n=49, SNAP n=201, uninformative/inconclusive n=286, intermediate-AD-likelihood n=350.§</s><s>Progression to non-AD dementia at follow-up was available in a subgroup of the samples: IWG-2 no prodromal AD n=433, prodromal AD n=293, NIA-AA low-AD-likelihood n=133, high-AD-likelihood n=343, IAP n=50, SNAP n=200, uninformative/inconclusive n=286, intermediate-AD-likelihood n=350.¶</s><s>p &lt;0.05 compared to the no prodromal Alzheimer's disease after FDR correction.A p&lt;0.05 compared to low-AD-likelihood after FDR correction.</s><s>B</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 : Frequency of risk factors for NIA-AA groups Risk factors</head><label>3</label><figDesc><div><p><s>= Alzheimer's disease, IAP = Isolated Amyloid pathology, SNAP = Suspected non-Alzheimer Pathophysiology.</s><s>Comparisons were corrected for baseline age, gender, years of education and center.</s><s>*p&lt;0.05 after FDR correction.</s></p></div></figDesc><table><row><cell></cell><cell>Low-AD-</cell><cell>High-AD-</cell><cell>IAP</cell><cell>SNAP</cell><cell>p-value</cell></row><row><cell></cell><cell>likelihood</cell><cell>likelihood</cell><cell></cell><cell></cell><cell>Low vs. High</cell></row><row><cell></cell><cell>N=142</cell><cell>N=356</cell><cell>N=54</cell><cell>N=206</cell><cell></cell></row><row><cell>Atherosclerotic disease (n=1002)</cell><cell>4%</cell><cell>10%</cell><cell>5%</cell><cell>9%</cell><cell>0.277</cell></row><row><cell>Depression (n=1129)</cell><cell>46%</cell><cell>17%*</cell><cell>27%</cell><cell>29%</cell><cell>0.004</cell></row><row><cell>Diabetes (n=914)</cell><cell>8%</cell><cell>9%</cell><cell>14%</cell><cell>15%</cell><cell>0.960</cell></row><row><cell>Hypercholesterolemia (n=1001)</cell><cell>43%</cell><cell>27%*</cell><cell>38%</cell><cell>38%</cell><cell>0.009</cell></row><row><cell>Hypertension (n=1346)</cell><cell>50%</cell><cell>47%</cell><cell>54%</cell><cell>47%</cell><cell>0.038</cell></row><row><cell>Lacunar infarct (n=497)</cell><cell>29%</cell><cell>23%</cell><cell>18%</cell><cell>30%</cell><cell>0.133</cell></row><row><cell>Stroke (n=1013)</cell><cell>3%</cell><cell>4%</cell><cell>6%</cell><cell>5%</cell><cell>0.787</cell></row><row><cell>Obesity (n=993)</cell><cell>21%</cell><cell>8%*</cell><cell>8%</cell><cell>18%</cell><cell>0.004</cell></row><row><cell>Smoking (n=1195)</cell><cell>53%</cell><cell>36%</cell><cell>40%</cell><cell>42%</cell><cell>0.076</cell></row><row><cell>Alcohol use (n=973)</cell><cell>42%</cell><cell>50%</cell><cell>50%</cell><cell>42%</cell><cell>0.352</cell></row></table><note><p><s>AD</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 : Effects of risk factors on cognitive decline Main effect risk factors Interaction with IWG-2 groups Interaction with NIA-AA groups</head><label>4</label><figDesc><div><p><s>Confidence Interval, HR = Hazard Ratio, IWG = International Working Group, NIA-AA = National Institute of Ageing Alzheimer's Association.</s><s>Cognitive decline is defined as progression to dementia or 3 points decline on MMSE at follow-up.</s><s>Hazard ratios and 95% CIs were calculated using Cox regression analyses and corrected for baseline age, gender, years of education and center.</s><s>*p&lt;0.05 after FDR correction.</s></p></div></figDesc><table><row><cell>Risk factors</cell><cell>HR</cell><cell>95%CI</cell><cell>p-value</cell><cell>HR</cell><cell>95%CI</cell><cell>p-value</cell><cell>HR</cell><cell>95%CI</cell><cell>p-value</cell></row><row><cell>Atherosclerotic disease</cell><cell>1.1</cell><cell>0.7 -1.7</cell><cell>0.825</cell><cell>0.5</cell><cell>0.2 -1.3</cell><cell>0.159</cell><cell>0.6</cell><cell>0.4 -1.1</cell><cell>0.119</cell></row><row><cell>Depression</cell><cell>0.7</cell><cell>0.5 -0.9</cell><cell>0.022</cell><cell>0.5</cell><cell>0.3 -0.9</cell><cell>0.048</cell><cell>0.8</cell><cell>0.6 -1.2</cell><cell>0.253</cell></row><row><cell>Diabetes</cell><cell>1.0</cell><cell>0.7 -1.6</cell><cell>0.907</cell><cell>1.1</cell><cell>0.4 -2.8</cell><cell>0.922</cell><cell>1.2</cell><cell>0.7 -2.3</cell><cell>0.501</cell></row><row><cell>Hypercholesterolemia</cell><cell>0.8</cell><cell>0.6 -1.0</cell><cell>0.080</cell><cell>2.2</cell><cell>1.2 -3.9</cell><cell>0.010</cell><cell>1.1</cell><cell>0.8 -1.5</cell><cell>0.624</cell></row><row><cell>Hypertension</cell><cell>0.7</cell><cell>0.4 -1.1</cell><cell>0.103</cell><cell>0.7</cell><cell>0.5 -1.1</cell><cell>0.103</cell><cell>0.8</cell><cell>0.6 -1.1</cell><cell>0.118</cell></row><row><cell>Lacunar infarct</cell><cell>0.8</cell><cell>0.3 -2.1</cell><cell>0.603</cell><cell>0.8</cell><cell>0.3 -2.1</cell><cell>0.603</cell><cell>0.8</cell><cell>0.4 -1.6</cell><cell>0.535</cell></row><row><cell>Stroke</cell><cell>1.0</cell><cell>0.6 -1.9</cell><cell>0.899</cell><cell>0.5</cell><cell>0.1 -1.5</cell><cell>0.201</cell><cell>0.7</cell><cell>0.4 -1.3</cell><cell>0.263</cell></row><row><cell>Obesity</cell><cell>0.7</cell><cell>0.4 -1.1</cell><cell>0.111</cell><cell>1.0</cell><cell>0.4 -2.6</cell><cell>0.993</cell><cell>1.1</cell><cell>0.6 -2.1</cell><cell>0.771</cell></row><row><cell>Smoking</cell><cell>1.2</cell><cell>0.9 -1.5</cell><cell>0.214</cell><cell>1.8</cell><cell>1.1 -3.0</cell><cell>0.017</cell><cell>1.2</cell><cell>0.9 -1.7</cell><cell>0.233</cell></row><row><cell>Alcohol use</cell><cell>1.5</cell><cell>1.2 -2.0</cell><cell>0.003*</cell><cell>0.8</cell><cell>0.5 -1.4</cell><cell>0.478</cell><cell>0.9</cell><cell>0.7 -1.3</cell><cell>0.624</cell></row><row><cell>CI =</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The diagnosis of mild cognitive impairment due to Alzheimer&apos;s disease: recommendations from the National Institute on Aging-Alzheimer&apos;s Association workgroups on diagnostic guidelines for Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Albert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Dekosky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dickson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dubois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gamst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Holtzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Jagust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Carrillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Thies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Phelps</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alzheimer&apos;s Association</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="270" to="279" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>Alzheimer&apos;s &amp; dementia : the journal of the</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Relationship between beta-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">D</forename><surname>Alcolea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carmona-Iragui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Suarez-Calvet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Sanchez-Saudinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Sala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Anton-Aguirre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blesa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Clarimon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fortea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lleo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Alzheimer&apos;s disease : JAD</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="157" to="167" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Anstey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Lipnicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Low</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="343" to="354" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Anstey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cherbuin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="542" to="555" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">Diagnostic and Statistical Manual of Mental Disorders: DSM-IV</title>
		<author>
			<persName><forename type="first">Apa</forename></persName>
		</author>
		<imprint>
			<date type="published" when="1994">1994</date>
			<publisher>American Psychiatric Association</publisher>
			<pubPlace>Washington, DC</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">I</forename><surname>Baldeiras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Santana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Proenca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Garrucho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pascoal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodrigues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Duro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Oliveira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Alzheimer&apos;s disease : JAD</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="117" to="128" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Controlled memory processes in questionable Alzheimer&apos;s disease: A view from neuroimaging research</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bastin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kerrouche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lekeu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Adam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Guillaume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lemaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Aerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ydewalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Collette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Salmon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Alzheimer&apos;s Disease</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="547" to="560" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Controlling the false discovery rate: a practical and powerful approach to multiple testing</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Benjamini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hochberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of the royal statistical society Series B (Methodological)</title>
		<imprint>
			<biblScope unit="page" from="289" to="300" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Vascular risk factors for Alzheimer&apos;s disease: an epidemiologic perspective</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Breteler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiology of aging</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="153" to="160" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Cardiovascular risk factors and future risk of Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>De Bruijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ikram</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">130</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment</title>
		<author>
			<persName><forename type="first">C</forename><surname>Decarli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Neurology</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="15" to="21" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies</title>
		<author>
			<persName><forename type="first">K</forename><surname>Deckers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Van Boxtel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Schiepers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Vugt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Munoz Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Anstey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brayne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Dartigues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Engedal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kivipelto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ritchie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Starr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yaffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Irving</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Verhey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kohler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International journal of geriatric psychiatry</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="234" to="246" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Defrancesco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Marksteiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Deisenhammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hinterhuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Weiss</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Association of Mild Cognitive Impairment (MCI) and depression</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Neuropsychiatr</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="144" to="150" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Advancing research diagnostic criteria for Alzheimer&apos;s disease: the IWG-2 criteria</title>
		<author>
			<persName><forename type="first">B</forename><surname>Dubois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jacova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hampel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Molinuevo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Blennow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Dekosky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gauthier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Selkoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bateman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cappa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Crutch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Engelborghs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Frisoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Galasko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Habert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Jicha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nordberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pasquier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rabinovici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Robert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Salloway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sarazin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Epelbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vellas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Stern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Scheltens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Cummings</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Neurology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="614" to="629" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Markers of Alzheimer&apos;s disease in a population attending a memory clinic</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Frisoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Prestia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Zanetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Galluzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Romano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cotelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gennarelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Binetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bocchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Paghera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Amicucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bonetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Benussi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ghidoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Geroldi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alzheimer&apos;s Association</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="307" to="317" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Alzheimer&apos;s &amp; dementia : the journal of the</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Gorelick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scuteri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Black</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Decarli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Iadecola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Launer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Laurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">L</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nyenhuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tzourio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Arnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Chui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Higashida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lindquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Roman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Sellke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Seshadri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke; a journal of cerebral circulation</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2672" to="2713" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>American Heart Association Stroke Council, C.o.E., Prevention, C.o.C.N.C.o.C.R., Intervention, Council on Cardiovascular</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Alcohol and cognitive impairment</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jauhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Advances in psychiatric treatment</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="304" to="313" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Adverse vascular risk is related to cognitive decline in older adults</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Jefferson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Hohman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Haj-Hassan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Gifford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Benson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Skinner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sparling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Sumner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Ruberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Alzheimer&apos;s disease : JAD</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1361" to="1373" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Accelerated weight loss may precede diagnosis in Alzheimer disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Wilkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of neurology</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1312" to="1317" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kaffashian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dugravot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Elbaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Shipley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sabia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kivimaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Singh-Manoux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1300" to="1306" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kivipelto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ngandu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fratiglioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Viitanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kareholt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Winblad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Helkala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tuomilehto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Soininen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nissinen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of neurology</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1556" to="1560" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kornhuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schmidtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Frolich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Perneczky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hampel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jessen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Heuser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Weih</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Luckhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Gertz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pantel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Rienhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Seuchter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ruther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Henn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Maier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wiltfang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dementia and geriatric cognitive disorders</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="404" to="417" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Data mining methods in the prediction of Dementia: A real-data comparison of the accuracy, sensitivity and specificity of linear discriminant analysis, logistic regression, neural networks, support vector machines, classification trees and random forests</title>
		<author>
			<persName><forename type="first">J</forename><surname>Maroco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodrigues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Guerreiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Santana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De Mendonca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC research notes</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">299</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Clinical diagnosis of Alzheimer&apos;s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer&apos;s Disease</title>
		<author>
			<persName><forename type="first">G</forename><surname>Mckhann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Drachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Folstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Katzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Stadlan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="939" to="944" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Resting metabolic connectivity in prodromal Alzheimer&apos;s disease. A European Alzheimer Disease Consortium (EADC) project</title>
		<author>
			<persName><forename type="first">S</forename><surname>Morbelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Drzezga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Perneczky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Frisoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Caroli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Van Berckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ossenkoppele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guedj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Didic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brugnolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sambuceti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pagani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Salmon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Nobili</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiology of aging</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2533" to="2550" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Ways toward an early diagnosis in Alzheimer&apos;s disease: the Alzheimer&apos;s Disease Neuroimaging Initiative (ADNI)</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Weiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Thal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Jack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Jagust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Trojanowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Toga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Beckett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alzheimer&apos;s Association</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="55" to="66" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>Alzheimer&apos;s &amp; dementia : the journal of the</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Pankratz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">O</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mielke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Knopman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Jack</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">E</forename><surname>Geda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Rocca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1433" to="1442" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Mild cognitive impairment as a diagnostic entity</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of internal medicine</title>
		<imprint>
			<biblScope unit="volume">256</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="183" to="194" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Risk and protective factors for cognitive impairment in persons aged 85 years and older</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">O</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Cha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mielke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">E</forename><surname>Geda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Boeve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Machulda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Knopman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="1854" to="1861" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Alcohol consumption and risk of dementia: the Rotterdam Study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ruitenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Van Swieten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Witteman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Van Duijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hofman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Breteler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">359</biblScope>
			<biblScope unit="issue">9303</biblScope>
			<biblScope unit="page" from="281" to="286" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Longitudinal changes of CSF biomarkers in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Seppala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Koivisto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hartikainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Helisalmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Soininen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Herukka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Alzheimer&apos;s disease : JAD</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="583" to="594" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<author>
			<persName><forename type="first">C</forename><surname>Somers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Goossens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Niemantsverdriet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Luyckx</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>De Roeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>De Roeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>De Vil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>De Deyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Bjerke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Engelborghs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<title level="m">press. A decade of cerebrospinal fluid biomarkers for Alzheimer&apos;s disease in</title>
				<meeting><address><addrLine>Belgium</addrLine></address></meeting>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Optimizing patient care and research: the Amsterdam Dementia Cohort</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Van Der Flier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Pijnenburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Prins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Lemstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Bouwman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Teunissen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Van Berckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Stam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Barkhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Van Egmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Scheltens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Alzheimer&apos;s disease : JAD</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="313" to="327" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Development of screening guidelines and clinical criteria for predementia Alzheimer&apos;s disease. The DESCRIPA Study</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Verhey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bullock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>De Deyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Frisoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Frolich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hampel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jolles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Minthon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Nobili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Olde Rikkert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Ousset</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Rigaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Scheltens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Soininen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Spiru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Touchon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsolaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vellas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">O</forename><surname>Wahlund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wilcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Winblad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroepidemiology</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="254" to="265" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Verhey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Frolich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kornhuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wiltfang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Maier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ruther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Nobili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Morbelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Frisoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Drzezga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Didic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Van Berckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Simmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Soininen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kloszewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mecocci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsolaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vellas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lovestone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Muscio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Herukka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Salmon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bastin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wallin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nordlund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De Mendonca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Santana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lemos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Engelborghs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Der Mussele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Freund-Levi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Wallin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hampel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Van Der Flier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Scheltens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Visser</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
